NIH, NIST researchers use artificial intelligence for quality control of stem cell-derived tissues

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).

 

11/14/2019 12:30 PM EST

Technique key to scale up manufacturing of therapies from induced pluripotent stem cells.